ALEXIS HARLAN: Open Payments
NPI 1386251411 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 65 payments from 15 companies in 2025. Trend: 2023 $896 · 2024 $698 · 2025 $1,375
Food & beverage: $1,276Education: $99
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 8 | $266 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $213 |
| Astellas Pharma US Inc | 4 | $199 |
| MILLICENT US INC | 18 | $193 |
| Sumitomo Pharma America, Inc. | 5 | $142 |
| SHIELD THERAPEUTICS INC | 4 | $89 |
| Exeltis, USA Inc. | 3 | $61 |
| Organon LLC | 3 | $43 |
| SANOFI PASTEUR INC. | 1 | $34 |
| Amgen Inc. | 2 | $29 |
Products named: ZURZUVAE, INTRAROSA, ANNOVERA, MYFEMBREE, Veozah, ACCRUFER, SLYND, NEXPLANON.
Industry payments across SC — which companies pay providers there.
